“Avicenna – A Strategy for in silico Clinical Trials” was a Coordination and Support Action funded by the European Commission. Avicenna was tasked with writing a Roadmap to define the strategy for developing In Silico Clinical Trials.
The main goal of the CombiMS project is to identify a new method for drug discovery based on systems biology and to validate this approach by identifying novel combination therapies for Multiple Sclerosis.
In this paper a validated gene regulatory network of T cell differentiation was constructed in order to identify potential early regulators of T cell associated diseases.
The ultimate aim of the Avicenna action is to create a research and technological development Roadmap outlining a strategy for in silico Clinical Trials.
The main goal of the PRIAT Project consists in the development and use of HLA peptidome analysis for the study of interpatient and intrapatient variations in the immunopeptidome in response to antibody treatment.
Develop the science of data synthesis to join up the myriad varieties of health information, insist Julian H. Elliott, Jeremy Grimshaw and colleagues at NATURE.
The presentations of the round-table discussion on “Big Data and Healthy Living Technologies”, chaired by BioHealth Computing coordinator, Prof. Philippe Sabatier are now available.